SARAH BOOSTROM, MD
Colon & Rectal Surgery Physician in PLANO, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: SARAH BOOSTROM, MD filed 197 Medicare Part D claims in 2023 across PLANO, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
SARAH BOOSTROM, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
SARAH BOOSTROM, MD at a glance
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Colon & Rectal Surgery Physician compares to other specialties among Texas providers
Colon & Rectal Surgery Physician share within Texas
Colon & Rectal Surgery Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Colon & Rectal Surgery Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Colon & Rectal Surgery Physician ABMS/AOA estimate
Est. board-certified rate (Colon & Rectal Surgery Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Colon & Rectal Surgery Physician US NPIs
Specialty board-certified rate — Colon & Rectal Surgery Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SARAH BOOSTROM, MD is a Colon & Rectal Surgery Physician provider practicing in PLANO, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1336269018. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
SARAH BOOSTROM, MD appears in the CMS NPPES registry as a Colon & Rectal Surgery Physician provider holding MD credentials at 1705 OHIO DR STE 100, PLANO, TX, 75093, with a listed phone of (972) 612-0430. NPI 1336269018 was issued on 03/29/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOOSTROM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 197 prescription claims written by this provider, covering 162 Medicare beneficiaries and totaling roughly $18K in drug spend, split 52% brand-name and 48% generic by claim count, with an opioid prescribing rate of 8.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Colon & Rectal Surgery Physician is a narrow specialty nationwide, with 1,608 enrolled providers across 50 states and an average of 196 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1336269018 |
|---|---|
| Specialty | Colon & Rectal Surgery Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/29/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SARAH BOOSTROM, MD's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where SARAH BOOSTROM, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SARAH BOOSTROM, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.0K
Largest payer
INTUITIVE SURGICAL, INC.
Most common payment type
Travel and Lodging
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to SARAH BOOSTROM, MD. To verify SARAH BOOSTROM, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
52% brand-name claims vs 48% generic, on 197 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 197
- Total Day Supply
- 594
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $15K
- Generic Drug Cost
- $3K
- Opioid Claims
- 17 (8.6% rate)
- Antibiotic Claims
- 36
Patient Demographics
- Average Patient Age
- 71.2 years
- Avg HCC Risk Score
- 0.84
- Gender Split
- 80% female / 20% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 71 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 18 |
| Oxycodone Hcl | 15 |
| Sod Sulf-Potass Sulf-Mag Sulf "Sodium | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Colon & Rectal Surgery Physician Overview
How SARAH BOOSTROM, MD fits within the Colon & Rectal Surgery Physician landscape nationally.
SARAH BOOSTROM, MD's 197 claims are above the specialty average of 196.
Nearby Colon & Rectal Surgery Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as BOOSTROM.
Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is SARAH BOOSTROM, MD's specialty? ▼
How much does SARAH BOOSTROM, MD prescribe under Medicare Part D? ▼
Where is SARAH BOOSTROM, MD located? ▼
What is SARAH BOOSTROM, MD's NPI number? ▼
Does SARAH BOOSTROM, MD prescribe more brand-name or generic drugs? ▼
Does SARAH BOOSTROM, MD prescribe opioids? ▼
How many Colon & Rectal Surgery Physician providers are there in the US? ▼
What drugs does SARAH BOOSTROM, MD prescribe most often? ▼
Does SARAH BOOSTROM, MD accept Medicare? ▼
How can I verify SARAH BOOSTROM, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology